Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous low-dose subcutaneous lidocaine for COVID-19 pneumonia
NL-OMON49706Phase 3Withdrawn
- Sponsor
- Stichting Dutch Covid19 Lidocaine ARDS
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine, sponsored by Stichting Dutch Covid19 Lidocaine ARDS. Planned start Apr 2020; status: withdrawn.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NL-OMON49706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49706.